IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q3 2014 Holdings

Filed 2014-11-14 | 10 holdings | $274.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Revance Therapeutics Inc(RVNCEUR)COM761330109$88.8K4,592,04732.3%
Abiomed Inc(ABMDEUR)COM003654100$78.2K3,150,00028.5%
Corium Intl IncCOM21887L107$57.4K9,353,30420.9%
Endologix IncCOM29266S106$31.6K2,514,93611.5%
Acura Pharmaceuticals IncCOM NEW00509L703$7.6K10,284,8862.8%
Ziopharm Oncology IncCOM98973P101$7.1K2,764,9082.6%
Medicinova Inc(MNOV)COM NEW58468P206$3.5K1,170,3701.3%
Curis IncCOM231269101$330233,7970.1%
Palatin Technologies IncCOM PAR $ .01696077403$2323,9280.0%
Echo Therapeutics IncCOM NEW27876L206$1012,3190.0%